SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-077551
Filing Date
2013-10-24
Accepted
2013-10-24 12:53:55
Documents
3
Period of Report
2013-10-24
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-22686_18k.htm 8-K 31810
2 EX-3.1 a13-22686_1ex3d1.htm EX-3.1 19170
3 EX-3.2 a13-22686_1ex3d2.htm EX-3.2 100102
  Complete submission text file 0001104659-13-077551.txt   152733
Mailing Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302 (201) 333-8819
OPTIMER PHARMACEUTICALS INC (Filer) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33291 | Film No.: 131167541
SIC: 2834 Pharmaceutical Preparations